ReviewBiomolecules & therapeutics2018
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities.
Byung-Jin Jung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this papercites it